Bellini M, Gambaccini D, Stasi C, Urbano MT, Marchi S, Usai-Satta P. Irritable bowel syndrome: A disease still searching for pathogenesis, diagnosis and therapy. World J Gastroenterol 2014; 20(27): 8807-8820 [PMID: 25083055 DOI: 10.3748/wjg.v20.i27.8807]
Corresponding Author of This Article
Massimo Bellini, MD, PhD, Gastrointestinal Unit, Department of Gastroenterology, University of Pisa, via Paradisa n 2, 56124 Pisa, Italy. mbellini@med.unipi.it
Research Domain of This Article
Gastroenterology & Hepatology
Article-Type of This Article
Topic Highlight
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Table 4 Indication of pharmacological agents in individual irritable bowel syndrome symptoms
Constipation
Diarrhoea
Pain
Soluble fibre
Opioid agents
Antispasmodics
Osmotic Laxative
5-HT3 antagonists
Peppermint oil
5-HT4 agonists
Probiotics
Serotoninergic drugs
Secretagogues
Antibiotics
Antidepressants
Probiotics
Mesalazine
Herbal therapy
SSRI
Colestyramine
Acupuncture
Tricyclic antidepressants
Citation: Bellini M, Gambaccini D, Stasi C, Urbano MT, Marchi S, Usai-Satta P. Irritable bowel syndrome: A disease still searching for pathogenesis, diagnosis and therapy. World J Gastroenterol 2014; 20(27): 8807-8820